標題
返回
確定
Topics
Business
Business
PR Newswire
AI & Semiconductor
AI & Semiconductor
Taiwan
Taiwan
Politics
Defense
Life
China
China
World
World
Editorial
Editorial
Topics
Business
Business
PR Newswire
AI & Semiconductor
AI & Semiconductor
Taiwan
Taiwan
Politics
Defense
Life
China
China
World
World
Editorial
Editorial
Business
AI & Semiconductor
Taiwan
China
World
Editorial
Business
AI & Semiconductor
Taiwan
China
World
Editorial
Business
AI & Semiconductor
Taiwan
China
World
Editorial
Home
autoimmune diseases
#
autoimmune diseases
About 7 search results
Sort by Date
Business
PR Newswire
HKeyBio Launches NHP Fast-Tox Program for Accelerating Non-GLP NHP Safety Risk Screening
The program supports early tolerability assessment, PK/TK-linked safety evaluation, immune-related risk screening, and pre-GLP dose design for biologics and immunomodulatory drug programs
PR Newswire
2026-06-24 20:36
NHP Fast-Tox
HkeyBio
Non-GLP NHP toxicology
Business
PR Newswire
Lynk Pharmaceuticals' Partner Formation Bio Doses First Participant in Phase 1 Trial of BLKR201 (originally designated as LNK01006), a CNS-Penetrant TYK2 Inhibitor
HANGZHOU, China, SHANGHAI and BOSTON
PR Newswire
2026-06-10 08:00
BLKR201
LNK01006
TYK2 inhibitor
Business
PR Newswire
China's Leading Innovative Drug Developer for Allergic and Autoimmune Diseases LongBio Pharma Lists on Hong Kong Stock Exchange
SHANGHAI
PR Newswire
2026-06-05 17:10
LongBio Pharma
Qiming Venture Partners
IPO
Business
PR Newswire
Mabwell's 9MW5211 Receives IND Clearance from NMPA for Inflammatory Bowel Disease
SHANGHAI
PR Newswire
2026-06-05 11:30
9MW5211
Mabwell
Inflammatory Bowel Disease
Business
PR Newswire
Everest Medicines Enters Commercialization License Agreement with Mabworks for Bejescin® in the Asia-Pacific Market
SHANGHAI
PR Newswire
2026-06-04 18:32
Everest Medicines
Mabworks
Bejescin
Business
PR Newswire
HkeyBio New Platform Launch: AIH, PBC, and IgAN Model Matrix Empowers "One Drug, Multiple Screens" in Autoimmune New Drug R&D
BOSTON and SUZHOU, China
PR Newswire
2026-06-03 22:00
HkeyBio
autoimmune diseases
Preclinical disease models
Business
PR Newswire
Antengene to Present First Preclinical Data on ATG-207 (αCD3-TGF-β Bifunctional Fusion Protein) at EULAR 2026
SHANGHAI and HONG KONG
PR Newswire
2026-06-03 12:00
ATG-207
Antengene
αCD3-TGF-β